Jacobs John C 4
4 · NOVAVAX INC · Filed Mar 4, 2025
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Jacobs John C
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2025-03-01$8.33/sh−38,451$320,297→ 136,732 total - Exercise/Conversion
Common Stock
2025-03-01+83,334→ 175,183 total - Exercise/Conversion
Restricted Stock Units
2025-03-01−83,334→ 166,666 totalExercise: $0.00Exp: 2034-03-01→ Common Stock (83,334 underlying)
Footnotes (1)
- [F1]One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.